Details for: RETEVMO
Company: LOXO ONCOLOGY INC
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
02516918 | RETEVMO | SELPERCATINIB | 40 MG | CAPSULE | ORAL |
02516926 | RETEVMO | SELPERCATINIB | 80 MG | CAPSULE | ORAL |
Summary Reports
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.